BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11262403)

  • 1. VP4 differentially regulates TRAF2 signaling, disengaging JNK activation while directing NF-kappa B to effect rotavirus-specific cellular responses.
    LaMonica R; Kocer SS; Nazarova J; Dowling W; Geimonen E; Shaw RD; Mackow ER
    J Biol Chem; 2001 Jun; 276(23):19889-96. PubMed ID: 11262403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.
    Darnay BG; Ni J; Moore PA; Aggarwal BB
    J Biol Chem; 1999 Mar; 274(12):7724-31. PubMed ID: 10075662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
    J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
    Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
    J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase.
    Akiba H; Nakano H; Nishinaka S; Shindo M; Kobata T; Atsuta M; Morimoto C; Ware CF; Malinin NL; Wallach D; Yagita H; Okumura K
    J Biol Chem; 1998 May; 273(21):13353-8. PubMed ID: 9582383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
    Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE
    Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.
    Pullen SS; Dang TT; Crute JJ; Kehry MR
    J Biol Chem; 1999 May; 274(20):14246-54. PubMed ID: 10318845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase.
    Darnay BG; Haridas V; Ni J; Moore PA; Aggarwal BB
    J Biol Chem; 1998 Aug; 273(32):20551-5. PubMed ID: 9685412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.
    Pomerantz JL; Baltimore D
    EMBO J; 1999 Dec; 18(23):6694-704. PubMed ID: 10581243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-kappaB activation but is dispensable for c-Jun N-terminal kinase signaling.
    Dadgostar H; Cheng G
    J Biol Chem; 1998 Sep; 273(38):24775-80. PubMed ID: 9733779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.
    Wong BR; Josien R; Lee SY; Vologodskaia M; Steinman RM; Choi Y
    J Biol Chem; 1998 Oct; 273(43):28355-9. PubMed ID: 9774460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.
    Habelhah H; Takahashi S; Cho SG; Kadoya T; Watanabe T; Ronai Z
    EMBO J; 2004 Jan; 23(2):322-32. PubMed ID: 14713952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of stress-activated protein kinase/c-Jun N-terminal kinase, but not NF-kappaB, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway.
    Shi CS; Kehrl JH
    J Biol Chem; 1997 Dec; 272(51):32102-7. PubMed ID: 9405407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase.
    Hatzoglou A; Roussel J; Bourgeade MF; Rogier E; Madry C; Inoue J; Devergne O; Tsapis A
    J Immunol; 2000 Aug; 165(3):1322-30. PubMed ID: 10903733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB.
    Lee SW; Han SI; Kim HH; Lee ZH
    J Biochem Mol Biol; 2002 Jul; 35(4):371-6. PubMed ID: 12296995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways.
    Hu WH; Johnson H; Shu HB
    J Biol Chem; 1999 Oct; 274(43):30603-10. PubMed ID: 10521444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.
    Eliopoulos AG; Waites ER; Blake SM; Davies C; Murray P; Young LS
    J Virol; 2003 Jan; 77(2):1316-28. PubMed ID: 12502848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2.
    Song HY; Régnier CH; Kirschning CJ; Goeddel DV; Rothe M
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9792-6. PubMed ID: 9275204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain.
    Baud V; Liu ZG; Bennett B; Suzuki N; Xia Y; Karin M
    Genes Dev; 1999 May; 13(10):1297-308. PubMed ID: 10346818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-kappaB activation induced by OX40 signaling.
    Takaori-Kondo A; Hori T; Fukunaga K; Morita R; Kawamata S; Uchiyama T
    Biochem Biophys Res Commun; 2000 Jun; 272(3):856-63. PubMed ID: 10860842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.